DRUG

86.22

3.56% 2.96

Handel nachbörslich: 85.89 -0.33 -0.38%

Bright Minds Biosciences Inc (DRUG)

Überblick Nachrichten Preisverlauf Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$83.26

Offen:

$83.6

24-Stunden-Volumen:

178.00K

Relative Volume:

1.19

Marktkapitalisierung:

$843.85M

Einnahmen:

Nettoeinkommen (Verlust:

$-14.23M

KGV:

-44.45

EPS:

-1.9396

Netto-Cashflow:

$-9.44M

1W Leistung:

-3.11%

1M Leistung:

+20.65%

6M Leistung:

+65.27%

1J Leistung:

+176.26%

1-Tages-Spanne:

$81.35

$87.36

1-Wochen-Bereich:

$81.29

$91.00

52-Wochen-Spanne:

$23.18

$123.75

Bright Minds Biosciences Inc Stock (DRUG) Company Profile

Firmenname

Bright Minds Biosciences Inc

Sektor

Healthcare (1106)

Branche

Biotechnology (615)

Telefon

Adresse

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-05-21

Neueste SEC-Einreichungen

DRUG's Discussions on Twitter

Compare DRUG vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
DRUG Bright Minds Biosciences Inc	86.22	814.88M	0	-14.23M	-9.44M	-1.9396
VRTX Vertex Pharmaceuticals Inc	424.36	109.34B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	702.27	74.35B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	794.70	50.44B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	301.11	39.78B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	297.49	33.02B	5.36B	287.73M	924.18M	2.5229

Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-13	Eingeleitet	Jefferies	Buy
2025-09-08	Eingeleitet	BTIG Research	Buy
2025-05-13	Eingeleitet	TD Cowen	Buy
2025-05-07	Eingeleitet	Chardan Capital Markets	Buy
2025-01-23	Eingeleitet	Piper Sandler	Overweight
2025-01-10	Eingeleitet	Cantor Fitzgerald	Overweight
2025-01-10	Eingeleitet	H.C. Wainwright	Buy
2024-11-26	Eingeleitet	Robert W. Baird	Outperform

Alle ansehen

Bright Minds Biosciences Inc Aktie (DRUG) Neueste Nachrichten

May 04, 2026

This Insider Has Just Sold Shares In Bright Minds Biosciences - simplywall.st

May 04, 2026

May 01, 2026

DRUG SEC FilingsBright Minds Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan

May 01, 2026

Apr 30, 2026

Cormorant sells $9.78m in Bright Minds Biosciences stock - Investing.com UK

Apr 30, 2026

[SCHEDULE 13G/A] BRIGHT MINDS BIOSCIENCES INC. Amended Passive Investment Disclosure - Stock Titan

Apr 30, 2026

Insider Selling: Bright Minds Biosciences (NASDAQ:DRUG) Major Shareholder Sells 109,331 Shares of Stock - MarketBeat

Apr 30, 2026

Bright Minds Biosciences (DRUG) holder sells 109,331 shares in open market - Stock Titan

Apr 30, 2026

Apr 27, 2026

Bright Minds announces ATM offering up to $100 million - MSN

Apr 27, 2026

Apr 26, 2026

How Bright Minds Biosciences Inc. (DRUG) Affects Rotational Strategy Timing - Stock Traders Daily

Apr 26, 2026

Apr 23, 2026

Bright Minds (DRUG) Year-Ahead Outlook | Q4 2025: Earnings ReportSurprise Score - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 23, 2026

Apr 22, 2026

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Apr 22, 2026

Top 3 Canadian Biotech Stocks in 2026 - Investing News Network

Apr 22, 2026

Apr 18, 2026

Bright Minds Biosciences (NASDAQ:DRUG) Downgraded to Sell Rating by Wall Street Zen - MarketBeat

Apr 18, 2026

Apr 16, 2026

Shroom stocks rise as Trump is said to sign executive order on psychedelic drug - Seeking Alpha

Apr 16, 2026

Apr 15, 2026

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Sees Significant Growth in Short Interest - MarketBeat

Apr 15, 2026

(DRUG) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Apr 15, 2026

Apr 13, 2026

Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from Analysts at Jefferies Financial Group - MarketBeat

Apr 13, 2026

Jefferies initiates Bright Minds stock with buy on epilepsy drug By Investing.com - Investing.com South Africa

Apr 13, 2026

Jefferies initiates Bright Minds stock with buy on epilepsy drug - Investing.com

Apr 13, 2026

Apr 09, 2026

Total debt per share of Bright Minds Biosciences Inc. – NEO:DRUG - TradingView

Apr 09, 2026

Apr 07, 2026

Certain RSUs of Bright Minds Biosciences Inc. are subject to a Lock-Up Agreement Ending on 8-APR-2026. - marketscreener.com

Apr 07, 2026

Certain Options of Bright Minds Biosciences Inc. are subject to a Lock-Up Agreement Ending on 8-APR-2026. - marketscreener.com

Apr 07, 2026

7,787,161 Common Shares of Bright Minds Biosciences Inc. are subject to a Lock-Up Agreement Ending on 8-APR-2026. - marketscreener.com

Apr 07, 2026

Bright Minds Biosciences (NASDAQ:DRUG) Shares Gap UpHere's Why - MarketBeat

Apr 07, 2026

Apr 06, 2026

Pullback Watch: Is Bright Minds Biosciences Inc a cyclical or defensive stockRecession Risk & Target Return Focused Stock Picks - baoquankhu1.vn

Apr 06, 2026

Bright Minds Biosciences (NASDAQ:DRUG) Trading 7.4% HigherWhat's Next? - MarketBeat

Apr 06, 2026

Sentiment Watch: What is PROVs 5 year growth outlookWeekly Profit Recap & Proven Capital Preservation Methods - baoquankhu1.vn

Apr 06, 2026

Apr 04, 2026

Responsive Playbooks and the DRUG Inflection - Stock Traders Daily

Apr 04, 2026

Apr 01, 2026